Patents by Inventor James G. Truslow

James G. Truslow has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Biomimetic microfluidic device for high efficiency carbon dioxide removal from patients at low blood flow rates
    Patent number: 11673094
    Abstract: The present disclosure discusses a system and method that includes a microfluidic device that can be used in either an extracorporeal or implantable configuration. The device supports efficient and safe removal of carbon dioxide from the blood of patients suffering from respiratory disease or injury. The microfluidic device can be a multilayer device that includes gas channels and fluid channels. Distensible membranes within the device can affect a cross-sectional area of the blood channels.
    Type: Grant
    Filed: May 26, 2017
    Date of Patent: June 13, 2023
    Assignee: The Charles Stark Draper Laboratory, Inc.
    Inventors: Jeffrey T. Borenstein, Alla A. Gimbel, Jose A. Santos, James G. Truslow
  • Method and Device for Exosomes Electroporation
    Publication number: 20190338235
    Abstract: Electroporation is conducted in a system comprising a central fluid stream shielded by fluid streams having different electrical conductivities. The streams can be supported by microchannels. In one example, an inner sheath fluid flow is supported by microchannels at each side of a central microchannel. An outer sheath fluid is supported by outer microchannels at the exterior of the inner sheath fluid flow microchannels.
    Type: Application
    Filed: May 1, 2019
    Publication date: November 7, 2019
    Inventors: Jonathan R. Coppeta, Vishal Tandon, James G. Truslow
  • BIOMIMETIC MICROFLUIDIC DEVICE FOR HIGH EFFICIENCY CARBON DIOXIDE REMOVAL FROM PATIENTS AT LOW BLOOD FLOW RATES
    Publication number: 20190184342
    Abstract: The present disclosure discusses a system and method that includes a microfluidic device that can be used in either an extracorporeal or implantable configuration. The device supports efficient and safe removal of carbon dioxide from the blood of patients suffering from respiratory disease or injury. The microfluidic device can be a multilayer device that includes gas channels and fluid channels. Distensible membranes within the device can affect a cross-sectional area of the blood channels.
    Type: Application
    Filed: May 26, 2017
    Publication date: June 20, 2019
    Inventors: Jeffrey T. Borenstein, Alla A. Gimbel, Jose A. Santos, James G. Truslow